TY - JOUR
T1 - Association between Cumulative Low-Density Lipoprotein Cholesterol Exposure during Young Adulthood and Middle Age and Risk of Cardiovascular Events
AU - Zhang, Yiyi
AU - Pletcher, Mark J.
AU - Vittinghoff, Eric
AU - Clemons, Autumn M.
AU - Jacobs, David R.
AU - Allen, Norrina B.
AU - Alonso, Alvaro
AU - Bellows, Brandon K.
AU - Oelsner, Elizabeth C.
AU - Zeki Al Hazzouri, Adina
AU - Kazi, Dhruv S.
AU - De Ferranti, Sarah D.
AU - Moran, Andrew E.
N1 - Funding Information:
Funding/Support: This study was supported by grants R01HL107475 (Dr Moran) and R01HL141823 (Drs Moran and de Ferranti) from the NIH.
Funding Information:
reported receiving grants from the National Institutes of Health (NIH) during the conduct of the study. Dr Vittinghoff reported receiving salary support from the NIH during the conduct of the study. Dr Allen reported receiving grants from the NIH and the American Heart Association outside the submitted work. Dr de Ferranti reported receiving personal fees from UpToDate Online outside the submitted work. Dr Alonso reported grants from NIH during the conduct of the study. Dr Oelsner reported grants from NIH during the conduct of the study. No other disclosures were reported.
Publisher Copyright:
© 2021 American Medical Association. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Importance: Low-density lipoprotein cholesterol (LDL-C) is a major risk factor for cardiovascular disease (CVD). Most observational studies on the association between LDL-C and CVD have focused on LDL-C level at a single time point (usually in middle or older age), and few studies have characterized long-term exposures to LDL-C and their role in CVD risk. Objective: To evaluate the associations of cumulative exposure to LDL-C, time-weighted average (TWA) LDL-C, and the LDL-C slope change during young adulthood and middle age with incident CVD later in life. Design, Setting, and Participants: This cohort study analyzed pooled data from 4 prospective cohort studies in the US (Atherosclerosis Risk in Communities Study, Coronary Artery Risk Development in Young Adults Study, Framingham Heart Study Offspring Cohort, and Multi-Ethnic Study of Atherosclerosis). Participants were included if they had 2 or more LDL-C measures that were at least 2 years apart between ages 18 and 60 years, with at least 1 of the LDL-C measures occurring during middle age at 40 to 60 years. Data from 1971 to 2017 were collected and analyzed from September 25, 2020, to January 10, 2021. Exposures: Cumulative exposure to LDL-C, TWA LDL-C, and LDL-C slope from age 18 to 60 years. Main Outcomes and Measures: Incident coronary heart disease (CHD), ischemic stroke, and heart failure (HF). Results: A total of 18288 participants were included in this study. These participants had a mean (SD) age of 56.4 (3.7) years and consisted of 10309 women (56.4%). During a median follow-up of 16 years, 1165 CHD, 599 ischemic stroke, and 1145 HF events occurred. In multivariable Cox proportional hazards regression models that adjusted for the most recent LDL-C level measured during middle age and for other CVD risk factors, the hazard ratios for CHD were as follows: 1.57 (95% CI, 1.10-2.23; P for trend =.01) for cumulative LDL-C level, 1.69 (95% CI, 1.23-2.31; P for trend <.001) for TWA LDL-C level, and 0.88 (95% CI, 0.69-1.12; P for trend =.28) for LDL-C slope. No association was found between any of the LDL-C variables and ischemic stroke or HF. Conclusions and Relevance: This cohort study showed that cumulative LDL-C and TWA LDL-C during young adulthood and middle age were associated with the risk of incident CHD, independent of midlife LDL-C level. These findings suggest that past levels of LDL-C may inform strategies for primary prevention of CHD and that maintaining optimal LDL-C levels at an earlier age may reduce the lifetime risk of developing atherosclerotic CVD..
AB - Importance: Low-density lipoprotein cholesterol (LDL-C) is a major risk factor for cardiovascular disease (CVD). Most observational studies on the association between LDL-C and CVD have focused on LDL-C level at a single time point (usually in middle or older age), and few studies have characterized long-term exposures to LDL-C and their role in CVD risk. Objective: To evaluate the associations of cumulative exposure to LDL-C, time-weighted average (TWA) LDL-C, and the LDL-C slope change during young adulthood and middle age with incident CVD later in life. Design, Setting, and Participants: This cohort study analyzed pooled data from 4 prospective cohort studies in the US (Atherosclerosis Risk in Communities Study, Coronary Artery Risk Development in Young Adults Study, Framingham Heart Study Offspring Cohort, and Multi-Ethnic Study of Atherosclerosis). Participants were included if they had 2 or more LDL-C measures that were at least 2 years apart between ages 18 and 60 years, with at least 1 of the LDL-C measures occurring during middle age at 40 to 60 years. Data from 1971 to 2017 were collected and analyzed from September 25, 2020, to January 10, 2021. Exposures: Cumulative exposure to LDL-C, TWA LDL-C, and LDL-C slope from age 18 to 60 years. Main Outcomes and Measures: Incident coronary heart disease (CHD), ischemic stroke, and heart failure (HF). Results: A total of 18288 participants were included in this study. These participants had a mean (SD) age of 56.4 (3.7) years and consisted of 10309 women (56.4%). During a median follow-up of 16 years, 1165 CHD, 599 ischemic stroke, and 1145 HF events occurred. In multivariable Cox proportional hazards regression models that adjusted for the most recent LDL-C level measured during middle age and for other CVD risk factors, the hazard ratios for CHD were as follows: 1.57 (95% CI, 1.10-2.23; P for trend =.01) for cumulative LDL-C level, 1.69 (95% CI, 1.23-2.31; P for trend <.001) for TWA LDL-C level, and 0.88 (95% CI, 0.69-1.12; P for trend =.28) for LDL-C slope. No association was found between any of the LDL-C variables and ischemic stroke or HF. Conclusions and Relevance: This cohort study showed that cumulative LDL-C and TWA LDL-C during young adulthood and middle age were associated with the risk of incident CHD, independent of midlife LDL-C level. These findings suggest that past levels of LDL-C may inform strategies for primary prevention of CHD and that maintaining optimal LDL-C levels at an earlier age may reduce the lifetime risk of developing atherosclerotic CVD..
UR - http://www.scopus.com/inward/record.url?scp=85115956542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85115956542&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2021.3508
DO - 10.1001/jamacardio.2021.3508
M3 - Article
C2 - 34550307
AN - SCOPUS:85115956542
SN - 2380-6583
VL - 6
SP - 1406
EP - 1413
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 12
ER -